|
|
||||||||
Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22908
| |
ABSTRACT |
|---|
|
|
|---|
The
relative contribution of xanthine oxidase (XO) and leukocytes to tissue
injury after short-term ischemia is unknown. In this study, we
subjected three groups of rat spinotrapezius muscles to 30-min
ischemia and 1-h reperfusion: 1)
ischemia-reperfusion (I/R) + 0.9% saline, 2) I/R + superoxide dismutase, and 3) I/R + oxypurinol. A
fourth group served as nonischemic control. We quantified
the increase in resistance (%
R) caused by
leukocyte-capillary plugging concurrently with myocyte uptake of
propidium iodide (PI) [expressed as no. of PI spots per total
volume of perfused tissue (NPI/V)] and
performed assays to quantify XO activity, thiobarbituric acid-reactive
substances (TBARS), and myeloperoxidase (MPO). Groups 2 and
3 exhibited significant decreases in NPI/V relative to group 1. MPO levels and TBARS were similar among
all groups, and mean %
R was significantly reduced in
groups 2 and 3 relative to group 1. However,
elevated XO was observed in groups 1 and 2 relative to
group 3 and nonischemic controls. These data are consistent
with the hypothesis that XO, rather than toxic species produced by
plugging or venule-adherent leukocytes, is responsible for postischemic
damage in this model.
xanthine oxidase; superoxide dismutase; oxypurinol; white blood cells; microcirculation
| |
INTRODUCTION |
|---|
|
|
|---|
IT HAS BEEN WIDELY DEMONSTRATED that ischemia resulting from such clinical conditions as hemorrhagic shock, stroke, local trauma, or myocardial infarction, followed by reperfusion of the tissue with oxygenated whole blood, can compromise microvascular and cellular integrity by causing swelling of endothelial cells (20), increased microvascular resistance associated with reductions in arteriolar diameter (27), leukocyte-capillary plugging (7, 11), and leukocyte adhesion to postcapillary venules with attendant permeability changes (5, 14, 18), phenomena that collectively contribute to ischemia-reperfusion (I/R) injury. The response of a tissue to reperfusion after ischemia may also be characterized by a "slow-reflow" or "no-reflow" response in which blood flow is reduced despite the restoration of normal perfusion pressures. The mechanisms of the no-reflow phenomenon and I/R-mediated tissue injury are still poorly understood despite extensive investigation.
Several reports suggested that leukocytes at least partially mediate
postischemic microvascular dysfunction (5, 14, 19). These studies
documented both significant leukocyte infiltration after I/R and
dramatic increases in resistance to tissue injury after I/R in
leukopenic animals compared with animals with normal numbers of
circulating leukocytes (19). The role of leukocytes in I/R is
multifaceted; they have been shown to play a role in increasing
permeability of postcapillary venules (14) and producing cytotoxic
mediators such as O
2 and proteases (13). Furthermore, activation of leukocytes and consequent stiffening caused by increases in cytoplasmic viscosity can retard leukocyte passage through capillaries (35), increase microvascular resistance (9), and in certain cases effect permanent flow stoppage.
Reactive oxygen species (ROS), especially
O
2, H2O2, and
OH · , have been implicated in both recruitment and
activation of leukocytes in I/R as well as I/R injury, on the basis of
evidence that scavenging of these radicals inhibits leukocyte adhesion,
infiltration, and the onset of tissue injury (2, 22). Support for the
chain of events implicating ROS in I/R injury stems from in vitro and
in vivo experiments in which application of specific ROS inhibitors
attenuated I/R injury. However, many sources of ROS may exist, and the
primary factors responsible for ROS production have not been clearly
defined. For example, ROS are produced by leukocytes (13), mast cells (16), capillary endothelial cells, and muscle cells (1). Many of the
intracellular enzymes involved, including xanthine oxidase (XO), have
been identified in several different I/R models (6, 8, 30). However,
the quantity of XO produced from its precursor xanthine dehydrogenase
(XDH) in skeletal muscle, particularly after short-term focal
ischemia, has not been extensively studied, and the
contribution of XO to ROS production relative to the other sources
mentioned above is also unknown.
Further complications in interpreting I/R data stem from the great number of indicators that have been used to assess tissue injury, including tissue-wide lipid peroxidation (17), increases in venular permeability (14), myeloperoxidase (MPO) activity (28), edema (15), functional capillary density (22), and uptake of nominally impermeant fluorescent dyes by nonviable cells (11, 12, 26, 31, 32). It is also worth noting that the utility of the latter indicators in assessing long-term, irreversible muscle injury has not been established. For example, propidium iodide (PI), a fluorescent DNA-binding marker, indicates that the nuclear membrane of stained cells is compromised (31), but it is unclear whether those muscle areas exhibiting significant nuclear fluorescence will experience long-term functional impairment or necrosis. A recent study indicates that an inverse correlation exists between muscle contractility and cellular uptake of PI after 1-h ischemia and up to 2-h reperfusion but does not prove a causal relation (32).
The study presented here was motivated in part by a recent investigation (11) in which a direct linear correlation was observed between the increases in microvascular resistance caused by leukocyte-capillary plugging and the extent of tissue injury as measured by the uptake of PI by myocytes. We used the short-term I/R model of Harris and Skalak (11) to examine several specific questions. First, we attempted to resolve whether plugging of capillaries by leukocytes is capable of injuring tissue or, conversely, whether tissue and capillary endothelium first damaged by other mechanisms restrict the passage of leukocytes and thereby effect increases in leukocyte-capillary plugging. Second, we attempted to resolve the contribution of all leukocytes (plugging, adherent, and extravasated) and tissue oxidants, specifically those derived from XO, to I/R-mediated tissue injury and microvascular resistance increases. Finally, we attempted to correlate tissue injury quantified by PI uptake with two standard biochemical injury markers, tissue MPO (28) and thiobarbituric acid-reactive substances (TBARS) (17).
| |
METHODS |
|---|
|
|
|---|
Surgical Protocol
Adult female Sprague-Dawley rats (Hilltop, Scottdale, PA) weighing 200-240 g were anesthetized by intramuscular injection of a 1%
-chloralose and 13.3% urethan solution (0.6 ml/100 g body wt). The
surgical protocol followed was reported in a previous study (10).
Briefly, the right spinotrapezius muscle was exteriorized, leaving the
anterior edge and main feeding vessels intact, and continuously
superfused with a physiological salt solution during the remainder of
the experiment. To enhance the clarity of the microvessels when viewed
through a microscope, the overlying fascia was carefully removed. The
lateral edge of the muscle, a thin section of tissue consisting of
well-ordered vascular networks fed by a single terminal arteriole and
drained by two collecting venules, was videotaped using an S-VHS
videocassette recorder (Panasonic model AG-1970) connected to the
microscope (Zeiss ACM) via a video camera (Dage-MTI model CCD-72) and a
microchannel plate intensifier (Dage Gen II). The muscle preparation
was allowed a minimum of 30 min to recover from surgery before
measurements were begun.
Ischemia Protocol and Microvascular Measurements
The protocol chosen conforms to that reported in a previous study (11). Briefly, after the selection of a microvascular network fed by one terminal arteriole and drained by two venules, a 30-min global ischemia was induced in the spinotrapezius muscle with the use of a micromanipulator to lower a blunt occlusion probe onto the main feeding artery and vein. Complete cessation of muscle blood flow was verified by scanning the tissue with a ×10 objective. The probe was removed at the end of the ischemic period, and video recording of leukocyte-capillary plugging was performed as described previously (9) with several minor alterations. Briefly, videotaping began at the distal end of the terminal arteriole with a ×63 objective. Individual branch points identified from the microvascular map were taped for 2 min, such that no downstream branch point was recorded unless all branch points upstream of it had already been recorded. If a vessel was plugged for longer than 2 min, videotaping of the bifurcation was extended in an attempt to determine the actual duration of the plug. Successive branch points were taped in this fashion until we reached the venous return, in which the daughter vessels were of larger diameter than the parent and white blood cell plugging did not occur. Finally, all vessels leading to the collecting venules were videotaped to facilitate measurement of their length and diameter.In addition, collecting venules of at least 12.7-µm diameter and 100-µm length that drained the selected network were each videotaped for 2 min both before the induction of ischemia and after 1-h reperfusion, and the flux of rolling and firmly adherent leukocytes was counted. Firmly adherent leukocytes were defined as those that remained stationary for at least 30 s.
Measurements of Tissue Injury
Propidium iodide.
PI, a fluorescent dye that has been used as a marker for cell death in
skeletal muscle (11, 12, 31, 32), was added to the superfusate at a
final concentration of 1 × 10
6 M immediately
before the network sketch. A minimum of 30 min was allowed for PI to
diffuse through the tissue and intercalate into the DNA of damaged
muscle cell nuclei. Quantification of network tissue injury was
performed by determining the total number of PI spots
(NPI) in the entire volume (V) of tissue perfused by the vascular network selected for study (11). Fluorescence visualization was performed using a ×40 water-immersion
objective, a microchannel plate intensifier, and a high-pass rhodamine
filter with a cutoff frequency of 590 nm. Clues to the identity of a fluorescent spot were present in the characteristic oval shape of
muscle cell nuclei as well as the appearance of several such spots
linearly within the edge of a muscle fiber. The volume of tissue
containing the network selected for study was examined sequentially one
field of view at a time, and NPI was counted.
2 mm3 to
facilitate network comparisons.
TBARS assay. To obtain a tissue-wide index of lipid peroxidation, the postischemic muscles of five animals from each experimental group were subjected to the protocol of Ohkawa et al. (25), except that an additional step to precipitate residual hemoglobin in the tissue homogenate was performed by application of Tsuchihashi's reagent (chloroform-ethanol, 2:3 vol/vol) followed by centrifugation at 15,000 g for 15 min. Spectrophotometric analysis was performed at 532 nm using 1,1,3,3-tetramethoxypropane as an external standard. As a positive control for this assay, nonischemic spinotrapezius muscles of four rats were homogenized (25) after a 1-h incubation of the tissue in a 1% solution of FeCl3. The aqueous ferric ion produces sufficient lipid peroxidation in animal tissues to be quantified by the TBARS assay (33). Levels of TBARS are reported as nanomoles per milligram of wet tissue.
MPO activity.
A previously published protocol was followed to quantify tissue MPO
levels (28). Positive controls for the MPO assay were provided by the
spinotrapezius muscles of four nonischemic rats 2-3 h after
pretreatment with tumor necrosis factor-
(5 µg ip) and 30 min
after superfusion of the exposed tissue with 10
6 M
N-formylmethionyl-leucyl-phenylalanine (fMLP). Significant numbers of rolling, adherent, and extravasated leukocytes were observed
in these preparations, as expected.
XO activity. Tissue XO and XDH activities were determined for each treatment group using a previously published protocol (30). To ensure the specificity of the assay, oxypurinol (100 µM) was added to each sample before spectrophotometry. Values of XO and XDH are reported as units per gram of wet tissue; 1 unit was defined as the quantity necessary to convert 1 µmol of xanthine to uric acid in 1 min.
Collection of plugging data and calculation of increase in network
resistance.
Plug duration and network dimensional data were obtained from the
recordings as previously reported (9). The total time a bifurcation was
plugged was divided by the 2-min observation period to determine a
plugging fraction for each bifurcation. These plugging fractions were
weighted in a computer model of the actual network (34) to determine
the overall increase in network resistance (%
R) caused by
leukocyte-capillary plugging. A separate model network was created for
each experiment, because each yielded a different network topology. Two
major assumptions were made for these simplified networks. First, the
pressure in the two collecting venules was presumed to be equal in the
model, which includes only one output node. Second, variation in a
vessel's diameter over its length was neglected; measurements taken at its entrance, midpoint, and exit were averaged to produce the diameter
used by the model. Under control conditions, these diameters were
approximately equal; however, after I/R, capillary narrowing often
occurred, which significantly altered the diameter of the vessel at one or more locations. Cross-connections in the
vasculature were included in the analysis. %
R caused by
leukocyte-capillary plugging was not determined under control
conditions, because this value has previously been established as
~1% in rat spinotrapezius muscle single networks (9).
I/R protocols. Four separate groups were studied. In nonischemic animals (n = 7) used to control for damage caused by surgical trauma and prolonged muscle exteriorization, surgical exteriorization of the spinotrapezius muscle was performed but no further manipulations were made. Tissue injury along the lateral edge of the muscle was quantified 45 min and 2.5 h after stabilization to provide baseline measurements for the preischemia and postreperfusion (1 h) measurements in the following protocols. Leukocyte rolling and adhesion were assessed at both time points.
For the I/R + saline group (n = 7), the I/R protocol was followed in its entirety. Additionally, 15 min before removal of the ischemia probe, a 1.0-ml bolus of 0.9% saline solution was infused via the femoral catheter. This was followed by constant infusion of a total volume of 1.5 ml of 0.9% saline solution during the reperfusion period. For the I/R + superoxide dismutase (SOD) group (n = 9), the protocol for the I/R + saline group was followed, but a bolus of 9.0 mg/kg SOD from bovine erythrocytes (Sigma) dissolved in 0.9% saline was administered 15 min before removal of the probe, followed by a constant infusion of 4.5 mg/kg (a total volume of 1.5 ml) during the reperfusion period. The initial concentration was within the range of values reported previously to significantly decrease tissue injury after I/R (2). For the I/R + oxypurinol group (n = 7), the spinotrapezius muscle was subjected to 30-min ischemia and 1-h reperfusion, but the animal was treated 15 min before reperfusion with 40 mg/kg oxypurinol (Sigma), an inhibitor of XO, dissolved in 0.9% isotonic saline and administered via the femoral vein catheter as described for the I/R + SOD group.Statistical Analyses
Statistical analyses were performed using the NCSS statistical software package. Means among many groups were compared with a one-way ANOVA, and a Student's t-test was used to compare means of two groups. Slopes of linear regressions were compared using an analysis of covariance. Significance is assumed at the 95% confidence level.| |
RESULTS |
|---|
|
|
|---|
Nonischemic Controls
Mean NPI/V was determined to be 6.57 ± 1.58/10
2 mm3 (Fig.
1A), indicating a small level of
surgical trauma. Note that the x-axis labels were
deliberately omitted from Fig. 1A to indicate that damage
caused by surgical trauma is independent of the resistance increase
caused by leukocyte-capillary plugging (
%R) (10). Qualitatively, all muscles appeared to be free from edema, capillaries appeared well perfused, and local muscle swellings were rare, indicating that the nonischemic muscle was in fairly good condition 3 h
after exteriorization.
|
I/R + Saline Group
The mean ± SE values for %
R and NPI/V were
13.4 ± 2.89% and 23.9 ± 10/10
2
mm3, respectively (Fig. 1B), similar to previously
reported values in the same model (11). Qualitatively, after 1-h
reperfusion, tissue edema and local muscle cell swelling were common
throughout the muscle and perfusion appeared reduced in areas, although
large reductions in capillary diameter were rare.
I/R + SOD Group
Mean %
R and NPI/V were 4.92 ± 1.56% and 5.88 ± 1.21/10
2 mm3, respectively (Fig.
1C), and were significantly different from the values for the
I/R + saline group (P < 0.02 and P < 0.0005, respectively), but NPI/V was comparable to that in
the nonischemic control group (P > 0.05). Qualitatively, the
muscles appeared well perfused throughout. Occasional networks
exhibited intermittent flow, a phenomenon not observed in the group not
exposed to I/R. Furthermore, local muscle cell swelling and large
reductions in capillary diameter were not present.
I/R + Oxypurinol Group
Mean %
R and NPI/V were 4.5 ± 2.7% and 10.2 ± 3.5/10
2 mm3, respectively (Fig.
1D), and were significantly reduced relative to the I/R + saline group (both P < 0.05), but
NPI/V was comparable to that in the nonischemic
control group. Qualitatively, tissues in this group appeared to be in
good condition; muscle fibers exhibited little or no swelling, and
capillaries were well perfused.
Correlations of Tissue Injury With Capillary Network Resistance
In Figure 1, B-D, correlations between tissue injury as measured by NPI/V and %
R are reported. Mean
NPI/V and mean %
R were both significantly
reduced in the I/R + SOD and I/R + oxypurinol groups relative to the
I/R + saline group (P < 0.0005, P < 0.02, respectively ). Additionally, the slope of the linear regression to the
I/R + saline data (r2 = 0.834) was significantly
different from zero (P < 0.005), whereas that of the linear
regression to the I/R + SOD and I/R + oxypurinol data
(r2 = 0.094) was not significantly different from
zero (both P < 0.02).
ANOVA and Student's t-tests both indicate that no significant
difference exists in (NPI/V)mean among
the nonischemic control, I/R + SOD, and I/R + oxypurinol groups (all
P > 0.05). Thus treatment of the muscles with SOD or
oxypurinol appears to have reduced tissue injury to the level of the
nonischemic control after 1.5-h I/R, and the level of injury appears to
be constant and independent of %
R.
Leukocyte Rolling, Adhesion, and Emigration
The fraction of the total number of leukocytes passing through postcapillary venules found rolling on the venular endothelium is reported in Fig. 2. The mean fraction of rolling leukocytes was 0.21 ± 0.04 in the nonischemic control group and 0.26 ± 0.03, 0.25 ± 0.04, and 0.24 ± 0.05 in the I/R + saline, I/R + SOD, and I/R + oxypurinol groups, respectively. No significant difference was evident between any of these treatment groups (P > 0.05), suggesting that treatment did not affect the proportion of rolling leukocytes.
|
In Fig. 3, the mean number of leukocytes
firmly adherent to 100-µm sections of the venular endothelium is
reported. The mean number of adherent leukocytes was 1.4 ± 0.37, 4.5 ± 1.26, 2.36 ± 0.51, and 4.0 ± 0.95 for the nonischemic control,
I/R + saline, I/R + SOD, and I/R + oxypurinol groups, respectively. The
range of collecting venule diameters studied fell between 25 and 30 µm for every group, and thus differences in vessel surface area were
small. No significant difference existed between the nonischemic control and I/R + SOD groups (P > 0.05), but the I/R + saline group exhibited a significant increase in leukocyte adherence relative
to the nonischemic control and I/R + SOD groups (both P < 0.05). In addition, the I/R + oxypurinol group exhibited a significant
increase in leukocyte adherence relative to the nonischemic control
group (P < 0.01). Thus oxypurinol prevented tissue
injury, whereas SOD effectively prevented both tissue injury and
leukocyte adhesion.
|
Giemsa staining of fixed, whole-mount tissues and intravital tracking of individual adherent leukocytes labeled with the fluorescent marker acridine red revealed no extravasated leukocytes in any treatment group by the end point of the study (data not shown).
Lipid Peroxidation
Mean tissue lipid peroxidation (MLP) as quantified by the TBARS assay is presented in Fig. 4. For the nonischemic control group, MLP was 0.64 ± 0.13 nmol/mg tissue, whereas MLP was 0.71 ± 0.27, 0.65 ± 0.18, and 0.59 ± 0.11 for the I/R + saline, I/R + SOD, and I/R + oxypurinol groups, respectively. None of the experimental treatments caused levels of lipid peroxidation significantly greater than that observed in the nonischemic control group (all P > 0.05), indicating that cellular damage assessed by this method was minimal after the short-term I/R protocol. MLP in muscles treated with 1% FeCl3, however, was 2.4 ± 0.2 and significantly greater (all P < 0.0001) than all treatment groups, suggesting that the treatment groups exhibited a small level of lipid peroxidation.
|
XO Activity
Tissue-wide levels of XO and XO + XDH activity are reported in Fig. 5. The total activity in each treatment group was ~9 mU/g wet tissue; these values were not significantly different (all P > 0.05). The mean values for XO activity were 2.15 ± 0.55, 4.33 ± 0.53, 5.58 ± 0.19, and 1.99 ± 0.41 mU/g for the nonischemic control, I/R + saline, I/R + SOD, and I/R + oxypurinol groups, respectively. Although no significant differences exist between means of the oxypurinol-treated group and the nonischemic group (P > 0.05), significant differences do exist between means of the I/R + saline and nonischemic control groups (P < 0.05) as well as between the I/R + SOD and nonischemic control groups (P < 0.05).
|
Tissue MPO
Mean levels of tissue MPO are reported in Fig. 6. For the nonischemic control group, the MPO value was 0.35 ± 0.11 U/µg protein, and the values were 0.31 ± 0.05, 0.34 ± 0.03, and 0.35 ± 0.06 U/µg protein for the I/R + saline, I/R + SOD, and I/R + oxypurinol groups, respectively. The differences between means were not statistically significant between any treatment groups; however, the means of all treatment groups were significantly reduced relative to the positive control values of 1.7 ± 0.04 U/µg protein (all P < 0.005), suggesting that limited tissue leukocyte accumulation occurred in all treatment groups.
|
| |
DISCUSSION |
|---|
|
|
|---|
Role of XO
Data obtained from other skeletal muscle I/R experiments (2, 3, 23) indicated that scavenging of O
2 effectively reduces tissue injury. However, the source of
O
2 has not been characterized in the
majority of these models. Those investigations that have assayed for
the presence of XO suggest that a quantity sufficient to cause tissue
injury is produced in postischemic skeletal muscle, dependent on both
the length of the ischemic insult and the species of animal (6, 17, 18,
30). Collectively, the data from the present study suggest that
O
2 and the products derived from it
are responsible for the majority of the tissue damage caused by I/R and
furthermore suggest that the primary source of the produced O
2 is tissue-derived XO and not
leukocytes. This hypothesis is consistent with the results of Suematsu
et al. (31) and Suzuki et al. (32), who have successfully used the free
radical scavengers dimethylthiourea, SOD, and a novel inhibitor of XO
to reduce myocyte PI uptake in a 1-h rat spinotrapezius ischemia model.
In nonischemic tissues, XO exists primarily in the NAD+-reducing XDH form (36) that is incapable of oxidant production. However, conversion of XDH to XO (D-O form conversion) has been shown to occur in liver (36), mesentery (8), and skeletal muscle after 2-h ischemia and 30-min reperfusion (30). We show here that after short-term (30-min) ischemic insult and 1-h reperfusion, significant conversion of D-O form occurs and approaches 50-60% of the total enzyme present (Fig. 5). These values are smaller than the 70-80% conversion reported by Smith et al. (30) after 2-h ischemia and 30-min reperfusion, suggesting that a more severe ischemic insult may be required to cause greater D-O conversion. However, short-term I/R was sufficient to effect a significant increase in XO beyond that of nonischemic controls in both the I/R + saline and I/R + SOD groups (Fig. 5), suggesting that a quantity of XO sufficient to generate superoxide radicals may be present in these two groups.
XO inhibition with oxypurinol was as effective as SOD infusion in reducing tissue injury as measured by NPI/V to levels of the nonischemic control group (Fig. 1, C and D). Concentrations of oxypurinol similar to that used here have also been used to effectively reduce tissue injury in a canine gracilis muscle model (30), and the present data support this report of its effectiveness in this regard. It is worthwhile to note, however, that although NPI/V was reduced in the I/R + oxypurinol group to the level of the nonischemic control group, the dose of oxypurinol administered did not abolish all XO activity. The residual activity, ~20% of the total XDH + XO, is again comparable to that of the nonischemic control group. There are at least two explanations for these observations. First, free XO present in the blood may bind some quantity of infused oxypurinol, reducing the free stream pool available for diffusion into endothelial cells and parenchymal cells. Second, the sensitivity of the assay is 1 mU/g (21); thus the oxypurinol levels may be indistinguishable from controls with this signal resolution. In any case, both tissue damage and XO activity in I/R + oxypurinol were reduced to the level of the nonischemic control group, suggesting that despite the possibility of incomplete XO inhibition, the quantity of oxypurinol administered had a functionally prophylactic effect, a possibility supported by the finding that administration of higher doses of oxypurinol did not result in further decreases in NPI/V or further reduction of XO activity (data not shown).
Microvascular Resistance Changes
In addition to the reduction in NPI/V in the I/R + oxypurinol and I/R + SOD groups relative to the I/R + saline group, Fig. 1, C and D, indicates the novel result that %
R is also reduced. The maximum %
R
(%
Rmax) observed in the I/R + oxypurinol group was 9.4%, greatly reduced from a %
Rmax of
26.4% in the I/R + saline group (Fig. 1B) and comparable to
the %
Rmax of 13.4% observed in the I/R + SOD
group (Fig. 1C). Additionally, mean %
R is reduced relative to I/R + saline. Two mechanisms may explain these findings. The first, which is supported by qualitative observations of prolonged microvessel patency in the presence of both SOD and oxypurinol, is that
reductions in tissue edema and fiber swelling attenuate capillary
compression and subsequent leukocyte entrapment. This hypothesis is in
accordance with other skeletal muscle I/R data (12, 15). A second
possibility, however, is that leukocyte activation is itself reduced
because of the effects of oxypurinol and SOD, and thus very few
leukocytes would possess sufficient viscosity to plug capillaries of
their own accord (35). However, the majority of the data in both the
I/R + oxypurinol and I/R + SOD groups reflect incidences of
leukocyte-capillary plugging sufficient to effect a %
R of
~5-10%, a level greater than the 1% observed in untreated
spinotrapezius muscles (10). In addition, although leukocyte rolling
was reduced in both the I/R + SOD and I/R + oxypurinol groups and
adhesion was reduced in the I/R + SOD group, neither phenomenon was
completely abolished, suggesting that some leukocytes are becoming
activated. A direct measurement of leukocyte viscosity, or some other
quantitative indicator of cellular activation, would be required to
firmly establish the mechanism by which oxypurinol or SOD reduces
%
R.
Leukocyte Adhesion and Emigration
Many studies have indicated that oxygen radical scavengers such as SOD and allopurinol attenuate the leukocyte adhesion induced by I/R in skeletal muscle (2, 22), thereby reducing leukocyte activation and the ability of these cells to release cytotoxic species. In the present study, neither treatment affected the flux fraction of rolling leukocytes (Fig. 2), in accordance with previous data. However, leukocyte adherence was attenuated significantly in the presence of SOD relative to that in the I/R + saline group, and the concomitant decrease in NPI/V after SOD administration suggests that ROS and proteases produced by activated leukocytes contribute to tissue injury. In contrast, no reduction in adherence was observed in the I/R + oxypurinol group (Fig. 3), but the same significant decrease in NPI/V relative to I/R + saline was present as in I/R + SOD.As noted (see RESULTS), none of the experimental treatments resulted in quantifiable levels of leukocyte emigration. This observation is confirmed by the MPO measurement, which suggests that total leukocyte infiltration did not change as a result of I/R. However, NPI/V was significantly lower in the I/R + SOD and I/R + oxypurinol groups relative to the I/R + saline (cf. Figs. 1, A-C, 3, and 6). Together, these observations indicate that leukocyte infiltration, including that which might not be reflected in the MPO assay (because of sensitivity), did not contribute to elevated tissue injury. Furthermore, these data collectively suggest that tissue XO, not adherent or emigrated leukocytes, is responsible for the production of ROS that ultimately led to the tissue injury reflected by PI uptake.
Propidium Iodide and Spatially Distributed Tissue Injury
Previous investigations of I/R using PI as a tissue injury marker have shown that in general, injury spots were distributed within the tissue and did not appear to cluster in locations that possess a high density of adherent and emigrated leukocytes, such as postcapillary venules (11, 31). The source of this distributed injury, its implication in long-term muscle survival, and its relation to better-characterized biochemical indexes of tissue injury are yet unknown. However, Suzuki and co-workers (32) indicate that PI uptake may be an effective measure of overall muscle function. These authors showed an inverse correlation between myocyte PI uptake and maximum tetanic force generated by rat spinotrapezius muscles after 1-h ischemia and 90-min reperfusion.Because some confirmation of the efficacy of PI as an injury measure relative to standard biochemical methods is warranted, the present study used both NPI/V and TBARS as indicators of tissue injury; although NPI/V changed significantly in the treatment groups relative to controls, the level of TBARS (Fig. 4) was not significantly different between and among treatment groups. Although the spectrophotometric assay used is not as sensitive as methods such as HPLC, other studies have shown its ability to measure increases in products of lipid peroxidation relative to nonischemic controls for ischemia of 3 h or longer (17). This suggests that the lack of discrepancy in the level of TBARS is not a sensitivity issue but, rather, the 30-min ischemic insult was not sufficient to produce a measurable level of lipid peroxidation. It is therefore conceivable that PI uptake may be indicative of short-term, reversible cell damage; however, PI-positive cells may also be more susceptible to a longer-term, more permanent damage that would in fact result in lipid peroxidation.
Previous reports of the mostly distributed nature of PI spots (11, 31)
were confirmed by the present study; a representative image is shown in
Fig. 7a. In addition, qualitative
tissue studies revealed that a fiber possessing a significant number of
fluorescent nuclei tended to exhibit PI fluorescence along the majority
of its length, whereas a neighboring fiber showed little, if any, PI
uptake (Fig. 7b). Although this observation was not
investigated extensively in this study, it lends support to the
hypothesis of Suematsu et al. (31), who presented immunohistochemical
evidence of a correlation between muscle fiber type and uptake of PI
after 1-h low-flow ischemia and 1-h reperfusion of rat
spinotrapezius muscles. Those authors observed elevated PI uptake by
type IIB (fast glycolytic) fibers relative to type I (slow oxidative)
fibers and argued that fiber susceptibility to low oxygen states may play an important role in postischemic complications. A more recent study describes preferential PI uptake after 2.5-h I/R by myocytes with
low mitochondrial volumes, as assessed by uptake of the fluorescent marker rhodamine 123, and further supports this hypothesis (32).
|
The leukocyte adherence, plugging, and MPO data, as well the XO assay, suggest further that the distributed injury is produced primarily by local XO-mediated ROS release, because XO is localized to most parenchymal and vascular endothelial cells (1). The alternative leukocyte-mediated mechanisms are not supported by the current data. For example, it would be expected that PI fluorescence would cluster around postcapillary venules if adherent, activated leukocytes caused cell damage, but PI clustering was not observed. Second, ROS release by leukocytes plugging capillaries may produce a distributed injury by local diffusion of ROS and proteases; in fact, a weak correlation between plugging sites and PI-positive cells has been demonstrated (11). However, a previous study failed to yield such a correlation (31). The lack of data concerning the activation state of plugging leukocytes after I/R and the further possibility that the incidence of leukocyte-capillary plugging is related not to their activation state but to tissue injury (as discussed earlier), make it difficult to lend support to the second hypothesis.
Third, the role of extravasated leukocytes is still undetermined, and
focal injury caused by a leukocyte migrating through the tissue may be
possible. A report on leukocyte extravasation in rat mesentery in
response to topical application of two chemotactic stimuli, fMLP and
histamine, showed that the velocity of a crawling leukocyte was ~19.8
µm/s and that emigrated leukocytes did not possess migration paths
directed toward any specific location in the tissue (24). If the
crawling velocity in skeletal muscle is similar, one leukocyte could
conceivably account for many PI spots. Two factors make this mechanism
of tissue injury unlikely in our model. First, because of the increased
number and density of parenchymal cells in skeletal muscle relative to
mesentery, the crawling velocity of a leukocyte may be expected to be
lower, making it less likely that one leukocyte could account for many injury locations. Second, as previously noted, we were unable to detect
extravasation of leukocytes after 1.5-h I/R. Hence, it is probable that
the short-term I/R insult reported here does not result in
extravasation of adherent leukocytes over the time frame studied and
thus that the speculated focal injury does not occur. Our MPO data also
argue against such a mechanism operating in this I/R model, but a study
tracking leukocyte emigration and a possible correlation with newly
fluorescent cellular nuclei is needed in a longer-term I/R setting (
4
h) to more clearly define the ability of emigrated leukocytes to
produce focal injury in skeletal muscle.
The present study supports the hypothesis that endothelial cell XO, not plugging or adherent leukocytes, is primarily responsible for tissue damage observed after short-term I/R. This hypothesis is in accordance with previous reports of leukocyte-independent postischemic damage after longer-term skeletal muscle ischemia (4, 29). Furthermore, pharmacological intervention with SOD and oxypurinol was effective in attenuating microvascular resistance increases caused by leukocyte-capillary plugging. Finally, damage quantified by PI uptake was spatially distributed throughout the tissue. Further work is warranted to fully explore the role of leukocytes in producing this distributed injury after both short- and long-term ischemia.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Klaus Ley (Univ. of Virginia), Dr. Lance Munn (Harvard Medical School), and Timothy Padera (Harvard Medical School) for helpful discussions of this work and critiques of the manuscript.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-49146, HL-52309, and HL-02372.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: T. C. Skalak, Dept. of Biomedical Engineering, Box 377, Health Sci. Ctr., Charlottesville, VA 22908 (E-mail: tskalak{at}virginia.edu).
Received 7 August 1998; accepted in final form 9 August 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Apple, F. S.,
J. E. Hyde,
A. M. Ingersoll-Stroubos,
and
A. Theologides.
Geographic distribution of xanthine oxidase, free radical scavengers, creatine kinase, and lactate dehydrogenase enzyme systems in rat heart and skeletal muscle.
Am. J. Anat.
192:
319-323,
1991[ISI][Medline].
2.
Becker, M.,
M. D. Menger,
and
H. A. Lehr.
Heparin-released superoxide dismutase inhibits postischemic leukocyte adhesion to venular endothelium.
Am. J. Physiol. Heart Circ. Physiol.
267:
H925-H930,
1994
3.
Blebea, J.,
J. C. Kerr,
R. W. Hobson II,
and
F. T. Padberg, Jr.
The effects of oxygen free radical scavengers on skeletal muscle ischemia and reperfusion injury.
Curr. Surg.
44:
396-398,
1987[Medline].
4.
Breidahl, A. F.,
M. J. Hickey,
A. G. Stewart,
P. G. Hayward,
and
W. A. Morrison.
Effects of low dose intra-arterial monoclonal antibodies to ICAM-1 and CD11/CD18 on local and systemic consequences of ischaemia-reperfusion injury in skeletal muscle.
Br. J. Plast. Surg.
49:
202-209,
1996[ISI][Medline].
5.
Carden, D. L.,
J. K. Smith,
and
R. J. Korthuis.
Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Role of granulocyte adherence.
Circ. Res.
66:
1436-1444,
1990
6.
Dorion, D.,
A. Zhong,
C. Chiu,
C. R. Forrest,
B. Boyd,
and
C. Y. Pang.
Role of xanthine oxidase in reperfusion injury of ischemic skeletal muscles in the pig and human.
J. Appl. Physiol.
75:
246-255,
1993
7.
Engler, R. L.,
G. W. Schmid-Schonbein,
and
R. S. Pavelec.
Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.
Am. J. Pathol.
111:
98-111,
1983[Abstract].
8.
Granger, D. N.
Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury.
Am. J. Physiol. Heart Circ. Physiol.
255:
H1269-H1275,
1988
9.
Harris, A. G.,
and
T. C. Skalak.
Effects of leukocyte activation on capillary hemodynamics in skeletal muscle.
Am. J. Physiol. Heart Circ. Physiol.
264:
H909-H916,
1993
10.
Harris, A. G.,
and
T. C. Skalak.
Leukocyte cytoskeletal structure determines capillary plugging and network resistance.
Am. J. Physiol. Heart Circ. Physiol.
265:
H1670-H1675,
1993
11.
Harris, A. G.,
and
T. C. Skalak.
Effects of leukocyte capillary plugging in skeletal muscle ischemia- reperfusion injury.
Am. J. Physiol. Heart Circ. Physiol.
271:
H2653-H2660,
1996
12.
Harris, A. G.,
M. Steinbauer,
R. Leiderer,
and
K. Messmer.
Role of leukocyte plugging and edema in skeletal muscle ischemia- reperfusion injury.
Am. J. Physiol. Heart Circ. Physiol.
273:
H989-H996,
1997
13.
Hernandez-Maldonado, J. J.,
E. Teehan,
C. D. Franco,
W. N. Duran,
and
R. W. Hobson II.
Superoxide anion production by leukocytes exposed to post-ischemic skeletal muscle.
J. Cardiovasc. Surg. (Torino)
33:
695-699,
1992[Medline].
14.
Jerome, S. N.,
T. Akimitsu,
and
R. J. Korthuis.
Leukocyte adhesion, edema, and development of postischemic capillary no-reflow.
Am. J. Physiol. Heart Circ. Physiol.
267:
H1329-H1336,
1994
15.
Jerome, S. N.,
C. W. Smith,
and
R. J. Korthuis.
CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon.
Am. J. Physiol. Heart Circ. Physiol.
264:
H479-H483,
1993
16.
Kanwar, S.,
and
P. Kubes.
Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction.
Am. J. Physiol. Gastrointest. Liver Physiol.
267:
G316-G321,
1994
17.
Kawasaki, S.,
S. Sugiyama,
N. Ishiguro,
T. Ozawa,
and
T. Miura.
Implication of superoxide radicals on ischemia-reperfusion-induced skeletal muscle injury in rats.
Eur. Surg. Res.
25:
129-136,
1993[ISI][Medline].
18.
Korthuis, R. J.,
D. N. Granger,
M. I. Townsley,
and
A. E. Taylor.
The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability.
Circ. Res.
57:
599-609,
1985
19.
Korthuis, R. J.,
M. B. Grisham,
and
D. N. Granger.
Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle.
Am. J. Physiol. Heart Circ. Physiol.
254:
H823-H827,
1988
20.
Mazzoni, M. C.,
K. C. Warnke,
K. E. Arfors,
and
T. C. Skalak.
Capillary hemodynamics in hemorrhagic shock and reperfusion: in vivo and model analysis.
Am. J. Physiol. Heart Circ. Physiol.
267:
H1928-H1935,
1994
21.
McKelvey, T. G.,
M. E. Hollwarth,
D. N. Granger,
T. D. Engerson,
U. Landler,
and
H. P. Jones.
Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney.
Am. J. Physiol. Gastrointest. Liver Physiol.
254:
G753-G760,
1988
22.
Menger, M. D.,
S. Pelikan,
D. Steiner,
and
K. Messmer.
Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox."
Am. J. Physiol. Heart Circ. Physiol.
263:
H1901-H1906,
1992
23.
Menger, M. D.,
D. Steiner,
and
K. Messmer.
Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow."
Am. J. Physiol. Heart Circ. Physiol.
263:
H1892-H1900,
1992
24.
Ohashi, K. L.,
D. K. Tung,
J. Wilson,
B. W. Zweifach,
and
G. W. Schmid-Schonbein.
Transvascular and interstitial migration of neutrophils in rat mesentery.
Microcirculation
3:
199-210,
1996[Medline].
25.
Ohkawa, H.,
N. Ohishi,
and
K. Yagi.
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.
Anal. Biochem.
95:
351-358,
1979[ISI][Medline].
26.
Potter, R. F.,
C. G. Ellis,
K. Tyml,
and
A. C. Groom.
Effect of superoxide dismutase and 21-aminosteroids (lazaroids) on microvascular perfusion following ischemia-reperfusion in skeletal muscle.
Int. J. Microcirc. Clin. Exp.
14:
313-318,
1994[ISI][Medline].
27.
Siemionow, M.,
W. Z. Wang,
G. Anderson,
and
J. Firrell.
Leukocyte-endothelial interaction and capillary perfusion in ischemia/reperfusion of the rat cremaster muscle.
Microcirc. Endothelium Lymphatics
7:
183-197,
1991[ISI][Medline].
28.
Sirsjo, A.,
D. H. Lewis,
and
G. Nylander.
The accumulation of polymorphonuclear leukocytes in post-ischemic skeletal muscle in the rat, measured by quantitating tissue myeloperoxidase.
Int. J. Microcirc. Clin. Exp.
9:
163-173,
1990[ISI][Medline].
29.
Skjeldal, S.,
A. Torvik,
B. Grogaard,
L. Nordsletten,
and
T. Lyberg.
Histological studies on postischemic rat skeletal muscles. With emphasis on the time of leukocyte invasion.
Eur. Surg. Res.
25:
348-357,
1993[ISI][Medline].
30.
Smith, J. K.,
D. L. Carden,
and
R. J. Korthuis.
Role of xanthine oxidase in postischemic microvascular injury in skeletal muscle.
Am. J. Physiol. Heart Circ. Physiol.
257:
H1782-H1789,
1989
31.
Suematsu, M.,
F. A. DeLano,
D. Poole,
R. L. Engler,
M. Miyasaka,
B. W. Zweifach,
and
G. W. Schmid-Schonbein.
Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation.
Lab. Invest.
70:
684-695,
1994[ISI][Medline].
32.
Suzuki, H.,
D. C. Poole,
B. W. Zweifach,
and
G. W. Schmid-Schonbein.
Temporal correlation between maximum tetanic force and cell death in postischemic rat skeletal muscle.
J. Clin. Invest.
96:
2892-2897,
1995.
33.
Valenzuela, A.
The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress.
Life Sci.
48:
301-309,
1991[ISI][Medline].
34.
Warnke, K. C.,
and
T. C. Skalak.
The effects of leukocytes on blood flow in a model skeletal muscle capillary network.
Microvasc. Res.
40:
118-136,
1990[ISI][Medline].
35.
Warnke, K. C.,
and
T. C. Skalak.
Leukocyte plugging in vivo in skeletal muscle arteriolar trees.
Am. J. Physiol. Heart Circ. Physiol.
262:
H1149-H1155,
1992
36.
Waud, W. R.,
and
K. V. Rajagopalan.
The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O).
Arch. Biochem. Biophys.
172:
365-379,
1976[ISI][Medline].
This article has been cited by other articles:
![]() |
R. W.R. Dudley, G. Danialou, K. Govindaraju, L. Lands, D. E. Eidelman, and B. J. Petrof Sarcolemmal Damage in Dystrophin Deficiency Is Modulated by Synergistic Interactions between Mechanical and Oxidative/Nitrosative Stresses Am. J. Pathol., April 1, 2006; 168(4): 1276 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertuglia, A. Giusti, and P. Del Soldato Antioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculation Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G437 - G443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertuglia and A. Giusti Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1064 - H1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zeng, H. Zhang, C. Lowell, and P. He Tumor necrosis factor-alpha -induced leukocyte adhesion and microvessel permeability Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2420 - H2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ozaki, S. Kawashima, T. Hirase, T. Yamashita, M. Namiki, N. Inoue, K.-i. Hirata, and M. Yokoyama Overexpression of Endothelial Nitric Oxide Synthase in Endothelial Cells Is Protective against Ischemia-Reperfusion Injury in Mouse Skeletal Muscle Am. J. Pathol., April 1, 2002; 160(4): 1335 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stupka and P. M. Tiidus Effects of ovariectomy and estrogen on ischemia-reperfusion injury in hindlimbs of female rats J Appl Physiol, October 1, 2001; 91(4): 1828 - 1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Reid Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Redox modulation of skeletal muscle contraction: what we know and what we don't J Appl Physiol, February 1, 2001; 90(2): 724 - 731. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||